Skip to main content
Livermore
Livermore
ZHEN

Egerton Capital (UK) LLP

SEC CIK
0001581811
Latest filing
Jul 21, 2026

The latest 13F from Egerton Capital (UK) LLP covers Q2 2026 (filed Jul 21, 2026): 23 long positions worth $10.4B. The top 10 holdings make up 76.0% of the portfolio, and the largest is Visa Inc. (V) at 14.1%. Livermore has 27 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
5
Est. +$904.1M
Added
13
Est. +$1.86B
Reduced
5
Est. −$862.2M
Sold out
6
Est. −$1.43B

Top 5 holdings

Share of this quarter's portfolio value

  1. VVisa Inc.
    14.1%$1.46BHistory
  2. GOOGAlphabet Inc.
    11.2%$1.16BHistory
  3. APHAmphenol Corp
    8.3%$858.1MHistory
  4. AMZNAmazon Com Inc
    8.2%$851.7MHistory
  5. MCOMoodys Corp
    7.5%$771.9MHistory

Share of portfolio

Top 5 holdings and the other 18 positions, by share of portfolio value

  1. V14.1%
  2. GOOG11.2%
  3. APH8.3%
  4. AMZN8.2%
  5. MCO7.5%
  6. Other 18 positions50.7%

Biggest buys

New and added positions, by estimated amount bought

  1. MDLNMedline Inc.
    +$477.4MAddedHistory
  2. AMATApplied Materials Inc
    +$376.7MNewHistory
  3. APHAmphenol Corp
    +$351.8MAddedHistory
  4. AMZNAmazon Com Inc
    +$288.4MAddedHistory
  5. EFXEquifax Inc
    +$235.1MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. APHAmphenol Corp
    +4.26 pp4.0% → 8.3%History
  2. MDLNMedline Inc.
    +4.12 pp2.2% → 6.3%History
  3. AMATApplied Materials Inc
    +3.64 pp0.0% → 3.6%History
  4. AMZNAmazon Com Inc
    +2.76 pp5.5% → 8.2%History
  5. EFXEquifax Inc
    +2.27 pp0.0% → 2.3%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. CRSCarpenter Technology Corp
    −$524.6MSold outHistory
  2. LINLinde PLC
    −$398.3MReducedHistory
  3. CMECME Group Inc.
    −$349.4MSold outHistory
  4. CNQCanadian Natural Resources Ltd
    −$277.1MSold outHistory
  5. IBKRInteractive Brokers Group, Inc.
    −$186.8MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. CRSCarpenter Technology Corp
    −5.82 pp5.8% → 0.0%History
  2. LINLinde PLC
    −4.37 pp5.9% → 1.5%History
  3. CMECME Group Inc.
    −3.88 pp3.9% → 0.0%History
  4. CNQCanadian Natural Resources Ltd
    −3.07 pp3.1% → 0.0%History
  5. UBERUber Technologies, Inc
    −2.10 pp3.7% → 1.6%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$10.4B
+$1.34B (+14.9%) vs. prior quarter
Positions
23
−1 vs. prior quarter
Top 10 concentration
76.0%
Top 10 as share of value
Turnover
23.7%
Q2 2026, one quarter
Average holding period
7.3 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $21.4B (Q4 2021)

Q1 2021: $19.0BQ2 2021: $20.1BQ3 2021: $21.0BQ4 2021: $21.4BQ1 2022: $19.0BQ2 2022: $14.8BQ3 2022: $12.9BQ4 2022: $11.6BQ1 2023: $9.26BQ2 2023: $9.70BQ3 2023: $8.62BQ4 2023: $9.23BQ1 2024: $10.3BQ2 2024: $9.90BQ3 2024: $9.91BQ4 2024: $8.65BQ1 2025: $8.67BQ2 2025: $9.75BQ3 2025: $9.48BQ4 2025: $9.20BQ1 2026: $9.01BQ2 2026: $10.4B
Q1 2021Q2 2026
13F filings of Egerton Capital (UK) LLP by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 21, 202623$10.4BVGOOGAPHvs. Q1 2026SEC
Q1 2026May 13, 202624$9.01BVGOOGMCOvs. Q4 2025SEC
Q4 2025Feb 11, 202623$9.20BAMZNVMSFTvs. Q3 2025SEC
Q3 2025Nov 12, 202524$9.48BMSFTAMZNVvs. Q2 2025SEC
Q2 2025Aug 12, 202525$9.75BMSFTAMZNPGRvs. Q1 2025SEC
Q1 2025May 6, 202527$8.67BAMZNPGRFISVvs. Q4 2024SEC
Q4 2024Feb 10, 202530$8.65BMSFTPGRAMZNvs. Q3 2024SEC
Q3 2024Nov 5, 202430$9.91BMSFTPGRCPvs. Q2 2024SEC
Q2 2024Aug 13, 202426$9.90BAMZNCPMETAvs. Q1 2024SEC
Q1 2024May 13, 202422$10.3BAMZNCPGEHCvs. Q4 2023SEC
Q4 2023Feb 12, 202422$9.23BVCPAMZNvs. Q3 2023SEC
Q3 2023Nov 13, 202322$8.62BCPVMETAvs. Q2 2023SEC
Q2 2023Aug 10, 202323$9.70BCPCNIVvs. Q1 2023SEC
Q1 2023May 9, 202325$9.26BCPCNIVvs. Q4 2022SEC
Q4 2022Feb 7, 202321$11.6BCPCNISCHWvs. Q3 2022SEC
Q3 2022Nov 10, 202223$12.9BCPCNIMSFTvs. Q2 2022SEC
Q2 2022Aug 9, 202226$14.8BCPMSFTCNIvs. Q1 2022SEC
Q1 2022Aug 3, 2022Amended29$19.0BCPGOOGMSFTvs. Q4 2021SEC
Q4 2021Aug 3, 2022Amended32$21.4BGOOGCPMSFTvs. Q3 2021SEC
Q3 2021Aug 3, 2022Amended34$21.0BGOOGCPCHTRvs. Q2 2021SEC
Q2 2021Aug 3, 2022Amended31$20.1BGOOGCPMSFTvs. Q1 2021SEC
Q1 2021Aug 3, 2022Amended35$19.0BGOOGMSFTCP–SEC

13D and 13G filings

Companies where Egerton Capital (UK) LLP reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Egerton Capital (UK) LLP does not currently report owning 5% or more of any company.

Latest filings

4 filings on file made by Egerton Capital (UK) LLP or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Egerton Capital (UK) LLP
CompanyFiled (ET)FormStakeChangeEvent dateFiling
FCNCAFirst Citizens Bancshares IncFeb 8, 202413G/AOld format–––SEC
FCNCAFirst Citizens Bancshares IncFeb 9, 202313GOld format–New–SEC
BBWIBath & Body Works, Inc.Feb 9, 202213G/AOld format–––SEC
BBWIBath & Body Works, Inc.Feb 10, 202113GOld format–New–SEC